Faisal Mahmood

Professor, Research unit of Oncology Oncology, Odense University Hospital faisal.mahmood@rsyd.dk
Research interests

DK: MR biomarkører for strålebehandlingsrespons, særligt diffusionsvægtet MR. Klassification af tumorer på baggrund af kvantitativ MR.

UK: MR biomarkers for radiation treatment response, especially diffusion barrier MR. Classification of tumours based on quantitative MR. 

 Workgroups Publications
  • Bernchou U, Christiansen RL, Bertelsen A, Tilly D, Riis HL, Jensen HR, Mahmood F, Hansen CR, Hansen VN, Schytte T, Brink C End-to-end validation of the geometric dose delivery performance of MR linac adaptive radiotherapy Phys Med Biol . 2021 Feb 12;66(4):045034 2021
  • Christiansen RL, Johansen J, Zukauskaite R, Hansen CR, Bertelsen AS, Hansen O, Mahmood F, Brink C, Bernchou U Accuracy of automatic structure propagation for daily magnetic resonance image-guided head and neck radiotherapy Acta Oncol . 2021 May;60(5):589-597 2021
  • Christiansen RL, Dysager L, Hansen CR, Jensen HR, Schytte T, Nyborg CJ, Bertelsen AS, Agergaard SN, Mahmood F, Hansen S, Hansen O, Brink C, Bernchou U Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment Radiother Oncol . 2022 Feb;167:165-171 2022
  • Bisgaard ALH, Brink C, Fransen ML, Schytte T, Behrens CP, Vogelius I, Nissen HD, Mahmood F Robust extraction of biological information from diffusion-weighted magnetic resonance imaging during radiotherapy using semi-automatic delineation Phys Imaging Radiat Oncol. 2022 Mar 7;21:146-152 2022
  • van Houdt PJ, Kallehauge JF, Tanderup K, Nout R, Zaletelj M, Tadic T, van Kesteren ZJ, van den Berg CAT, Georg D, Côté JC, Levesque IR, Swamidas J, Malinen E, Telliskivi S, Brynolfsson P, Mahmood F, van der Heide UA Phantom-based quality assurance for multicenter quantitative MRI in locally advanced cervical cancer Radiother Oncol . 2020 Dec;153:114-121 2020
  • Bertelsen AS, Schytte T, Møller PK, Mahmood F, Riis HL, Gottlieb KL, Agergaard SN, Dysager L, Hansen O, Gornitzka J, Veldhuizen E, ODwyer DB, Christiansen RL, Nielsen M, Jensen HR, Brink C, Bernchou U First clinical experiences with a high field 1.5 T MR linac. Acta Oncol. 2019 Oct;58(10):1352-1357. 2019
  • Mahmood F, Nielsen UG, Jørgensen CB, Brink C, Thomsen HS, Hansen RH Safety of gadolinium based contrast agents in magnetic resonance imaging-guided radiotherapy - An investigation of chelate stability using relaxometry Phys Imaging Radiat Oncol. 2022 Feb 26;21:96-100 2022
  • Bernchou U, Arnold TST, Axelsen B, Klüver-Kristensen M, Mahmood F, Harbo FSG, Asmussen JT, Hansen O, Bertelsen AS, Hansen S, Brink C, Dahlrot RH Evolution of the gross tumour volume extent during radiotherapy for glioblastomas Radiother Oncol. 2021 Jul;160:40-46 2021
  • Hasler SW, Bernchou U, Bertelsen A, van Veldhuizen E, Schytte T, Hansen VN, Brink C, Mahmood F Tumor-site specific geometric distortions in high field integrated magnetic resonance linear accelerator radiotherapy Phys Imaging Radiat Oncol . 2020 Aug 19;15:100-104 2020